Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms
Crossref DOI link: https://doi.org/10.1007/s00277-016-2915-4
Published Online: 2017-01-06
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Choi, DC
Tremblay, D
Iancu-Rubin, C
Mascarenhas, J http://orcid.org/0000-0002-8400-0483
License valid from 2017-01-06